Infantile hemangioma: a brief review

Authors

  • Madalina Bota
  • Gheorghe Popa
  • Cristina Blag
  • Alexandru Tataru

DOI:

https://doi.org/10.15386/cjmed-381

Keywords:

infantile hemangiomas, etiopathogenesis, therapy

Abstract

Infantile hemangiomas as frequent infancy tumors have been a controversial issue of medical scientists worldwide. Their clinical aspects are various and their physiopathology is yet to be fully understood. Numerous publications outline the characteristics, causes, evolution possibilities and therapeutic approaches. Deciding whether to treat or not is the main question of this kind of pathology. Hemangiomas that have complications or can cause irreversible damage need therapy. This is a brief review of up-to-date information regarding the presentation of infantile hemangiomas and target-therapies.

Author Biographies

Madalina Bota, University of Medicine and Pharmacy "Iuliu Hatieganu" Cluj Napoca, Department of Pediatrics II

Children's Hospital Cluj Napoca, Department of Pediatrics II

Gheorghe Popa, University of Medicine and Pharmacy "Iuliu Hatieganu" Cluj Napoca, Department of Pediatrics II

Children' s Hospital, Department of Pediatrics II

Cristina Blag, University of Medicine and Pharmacy "Iuliu Hatieganu" Cluj Napoca, Department of Pediatrics II

Children's Hospital, Department of Pediatrics II

Alexandru Tataru, University of Medicine and Pharmacy "Iuliu Hatieganu" Cluj Napoca, Department of Dermatology

Department of Dermatology

Downloads

Additional Files

Published

2015-01-28

How to Cite

1.
Bota M, Popa G, Blag C, Tataru A. Infantile hemangioma: a brief review. Med Pharm Rep [Internet]. 2015 Jan. 28 [cited 2025 Oct. 5];88(1):23-7. Available from: https://medpharmareports.com/index.php/mpr/article/view/381

Issue

Section

Reviews